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Abstract
Members of the Mycobacterium tuberculosis complex (MTC) are causative agents of human and animal tuberculosis. This complex encom-
passes several phylogenetically related species, including M. tuberculosis, the main aetiological agent of human tuberculosis, and Mycobac-
terium bovis, the causative agent of bovine tuberculosis, a relevant worldwide zoonosis. Clear epidemiological evaluation of appropriate
and effective treatment requires unambiguous differentiation between MTC members. Routine diagnosis has been increasingly relying on
the molecular identiﬁcation of MTC members. In the present study, we report the use of a gold nanoparticle-based approach for the
sensitive, speciﬁc and fast identiﬁcation of MTC and for the differentiation of M. bovis and M. tuberculosis using the gyrB locus as target.
This gold nanoprobe strategy relies on the colorimetric differentiation of speciﬁc DNA sequences based on differential aggregation pro-
ﬁles in the presence or absence of speciﬁc target hybridization. Three nanoprobes were designed and successfully used for the speciﬁc
identiﬁcation of members of MTC, M. bovis and M. tuberculosis.
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Introduction
Tuberculosis is a global health problem associated with signif-
icant morbidity, causing epidemics and resulting in the death
of approximately two million people per year [1].
This destructive disease is caused by members of the
Mycobacterium tuberculosis complex (MTC), a group of clo-
sely-related pathogenic species that includes M. tuberculosis,
Mycobacterium bovis, Mycobacterium caprae, Mycobacterium
africanum and Mycobacterium microti [2] .
Despite M. tuberculosis being the most common cause of
tuberculosis in humans, M. bovis is responsible for 0.5–7.2%
of human tuberculosis cases in industrialized nations and is
estimated to be responsible for 10–15% of new cases in the
developing world [3]. M. bovis is also the causative agent of
bovine tuberculosis, a zoonosis with high important socio-
economic and public health effects [1,4,5].
Rapid identiﬁcation of mycobacteria is of paramount
importance for unequivocal diagnostics leading to effective
infection control. During the past two decades, the develop-
ment of molecular detection and identiﬁcation methods using
several appropriate loci has allowed the rapid differentiation
between the members of the MTC [6–9]. These molecular
methods constitute an advantage over the more time-con-
suming and laborious biochemical characterization [10]. One
such molecular assay uses the ampliﬁcation of the gyrB gene,
coding for the B subunit of DNA gyrase (a type II topoisom-
erase) essential for bacterial replication, followed by analysis
of polymorphic sites via PCR-restriction fragment length
polymorphism (RFLP) [11,12].
The use of thiol-linked ssDNA-modiﬁed gold nanoparticles
(Au-nanoprobes) for the colorimetric detection of DNA tar-
gets represents an inexpensive and easy-to-perform alterna-
tive to common molecular assays [13–16]. The surface
plasmon resonance (SPR) of gold nanoparticles is responsible
for their intense colours. In solution, monodisperse gold
nanoparticles appear red and exhibit a relatively narrow SPR
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band centered around 520 nm in the UV-visible spectrum.
By contrast, a solution containing aggregated gold nanoparti-
cles appears blue, corresponding to a characteristic red shift
in the SPR band to higher wavelengths. Our method consists
in a visual and/or spectrophotometric comparison of solu-
tions before and after salt-induced Au-nanoprobe aggrega-
tion: the presence of complementary target preventing
aggregation and the solution remaining red. Noncomplemen-
tary/mismatched targets do not prevent Au-nanoprobe
aggregation, resulting in a visible change of colour from red
to blue. Speciﬁc DNA detection based on Au-nanoprobes
has proven to be a fast and simple alternative to more cum-
bersome techniques involving multistep assays. The non-
cross-linking method for DNA identiﬁcation has already been
successfully applied for the identiﬁcation of M. tuberculosis in
clinical samples based on the rpoB locus [17], gene expres-
sion studies and the detection of point mutations [18,19].
In the present study, we report an Au-nanoprobe-based
molecular detection assay capable of differentiating between
members of the MTC. Based on the gyrB locus, three speciﬁc
Au-nanoprobes were developed: one for identiﬁcation of
MTC, one for M. tuberculosis and another for M. bovis.
Materials and Methods
Strains analysed
In this study, several strains from MTC and non-MTC species
were used (Table 1.) The identiﬁcation of each strain was
certiﬁed by the National Laboratory of Veterinary Research
(INRB, I.P., LNIV), the Portuguese reference laboratory for
bovine tuberculosis, where gyrB-PCR-RFLP is routinely used
for the identiﬁcation of MTC species [8]. Strain cultivation and
DNA extraction from cultures were performed according to
standard methods described previously [20].
PCR ampliﬁcation of gyrB
The 1020-bp speciﬁc fragment of the gyrB gene, suitable for dif-
ferentiation of MTC members, was PCR ampliﬁed using a pro-
cedure adapted from Niemann et al. [12]. Brieﬂy, PCR
reactions were carried out in 25 ll using 200 lM of deoxynu-
cleotide triphosphates (Amersham Biosciences, Piscataway,
NJ, USA), 1 U of Taq DNA polymerase (Promega, Madison,
WI, USA), 2 mM of MgCl2 (Promega), 20 pmol of each primer
MTUB-f [5¢-TCG GAC GCG TAT GCG ATA TC-3¢] and
MTUB-r [5¢-ACA TAC AGT TCG GAC TTG CG-3¢] and 1 ll
of extracted DNA solution. Ampliﬁcation was performed in a
MJmini Thermocycler (Bio-Rad, Hercules, CA, USA) with 35
cycles of 1 min at 95C, 1.5 min at 55C, and 1.5 min at
72C. The PCR products were ethanol precipitated and resus-
pended in deionized water. The ampliﬁed products were
electrophoretically analysed in a 1.5% agarose gel (data not
shown).
Sequence analysis and probe design
Comparative analysis of gyrB gene sequences from mycobac-
teria was performed using sequence alignment with the
CLUSTAL X, version 2.0 [21]. Gene sequences were
retrieved from GenBank with accession numbers: AB014184
for M. bovis, AJ276122 for M. caprae, AB014205 for M. mic-
roti, Z80233 for M. tuberculosis, AB014202 for Mycobacterium
gastri, AB014189 for M. avium subsp. avium and EU029114
for M. avium subsp. paratuberculosis. Probe speciﬁcity was
tested in silico using the BLAST tools from GenBank. Speciﬁc
oligonucleotides for MTC, M. tuberculosis and M. bovis were
used to functionalize the gold nanoparticles and produce the
TABLE 1. Bacterial strains and clinical isolates used in the present study for the evaluation of speciﬁcity of the gold nanoprobe
assay
Species Strain*/clinical isolate gComplex gMTub gMBov
Mycobacterium tuberculosis ATCC 25177; LNIV 9605 + + )
Mycobacterium bovis AN5; LNIV 13027, 5530/0/05, 11265,
7230/4, 14421/2, 24497/6, 8855, 5889,
10044, 14577, 13280/6, 13280/4, 34875
and 20564
+ ) +
Mycobacterium bovis BCG ATCC 27291 + ) +
Mycobacterium caprae LNIV 17320, 4958/0/05, 8403, 15244
and 20752
+ ) )
Mycobacterium avium subsp. avium ATCC 25291 ) ) )
Mycobacterium avium subsp. paratuberculosis LNIV 39888 ) ) )
Mycobacterium avium subsp. hominissuis LNIV 23063/4 ) ) )
Corynebacterium striatum LNIV 12352 ) ) )
*ATCC, American Type Culture Collection, USA; LNIV, Laborato´rio Nacional de Investigac¸a˜o Veterina´ria, Lisbon, Portugal.
+, positive (no aggregation); ), negative (aggregation).
gComplex, gMTub and gMBov represent the speciﬁc Au-nanoprobe text with people speciﬁc for mT Complex, M. tuberculosis and M. bovis, respectively.
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Au-nanoprobes: MTC probe (gComplex), 5¢-thiol-CCGAG
GACACAGCCTTGTTC-3¢; M. tuberculosis probe (gMTub),
5¢-thiol-TTTGAAGCCAACCCCACCGACG-3¢; and M. bovis
probe (gMBov), 5¢-thiol-CGTTTGTGCAGAAGGTCTG
TAAT-3¢ (STAB Vida Lda, Portugal).
Gold nanoparticle and gold nanoprobe synthesis
Gold nanoparticles, with an average diameter of approxi-
mately 13 nm, were synthesized by the citrate reduction
method described by Lee and Meisel [22]. Brieﬂy, 250 ml of
1 mM HAuCl4 were heated with stirring, 25 ml of 28.8 nM
sodium citrate were added, and the solution was reﬂuxed
for 15 min. Afterwards, the solution was left at room tem-
perature to cool down. The gold nanoprobes were prepared
by incubating the thiol-modiﬁed oligonucleotides with the
gold nanoparticles for 16 h. The solution was washed with
phosphate buffer (pH 7), 10 mM, at increasing salt concen-
tration, aiming to reduce nonspeciﬁc bonds between the
thiol-modiﬁed oligonucleotides and the gold nanoparticles.
The solution was centrifuged and the resulting pellet was
resuspended in phosphate buffer (pH 7), 10 mM, 0.1 M
NaCl, and stored in the dark at 4C until further use.
Au-nanoprobe colorimetric assay conditions
Each colorimetric assay was performed in a total volume of
30 ll with Au-nanoprobes at a ﬁnal concentration of 2.5 nM
in phosphate buffer (pH 8), 10 mM, 0.5 M NaCl. For each
probe, the assay consisted in the visual/spectrophotometric
comparison of a ‘Blank’ [without DNA; phosphate buffer (pH
8), 10 mM, 0.5 M NaCl] with positive samples containing the
appropriate amplicon (ﬁnal concentration of 30 mg/L for the
M. tuberculosis probe and 10 mg/L for the MTC and M. bovis
probes) and with a negative sample containing noncomple-
mentary DNA (M. avium subsp. avium, M. avium subsp. para-
tuberculosis, M. avium subsp. hominissuis, Corynebacterium
striatum). After 10 min of denaturation at 95C, the mixtures
were allowed to stand for 30 min at room temperature and
MgCl2 was added to a ﬁnal concentration of 0.7 M for
M. tuberculosis and M. bovis probes and 0.04 M for the MTC
probe. After 15 min at room temperature for colour devel-
opment, the mixtures and the blank were assayed by UV-
visible spectroscopy in a microplate reader (Tecan Inﬁnite
M200; Tecan, Austria GmbH, Gro¨dig, Austria).
Results and Discussion
On the basis of the gyrB gene sequence conserved between
species of the MTC, a set of primers was used to PCR
amplify a speciﬁc 1020-bp fragment of the gene from MTC
species only (i.e. no amplicons were generated from non-
MTC species) [11,12]. In silico alignment of the gyrB gene
sequences showed three regions sufﬁcient to unequivocally
discriminate between MTC members (Fig. 1). For proof-of-
concept, we targeted this genomic region shared by all
members of the M. tuberculosis complex, and two further
probes were designed to speciﬁcally identify M. tuberculosis
and M. bovis. These sequences were taken for the design of
speciﬁc thiolated oligonucleotides, which were then used to
functionalize the gold nanoparticles. The MTC probe posi-
tively identiﬁed the members of the MTC used in the assay,
at the same time as clearly recognizing the nonmembers
(Fig. 2b; Table 1). The M. tuberculosis and M. bovis probes
unequivocally identiﬁed the respective target (Fig. 2b;
Table 1). Furthermore, blind identiﬁcation of mycobacteria
strains isolated from ﬁfteen different clinical samples
showed 100% concordance with the results obtained with
the gyrB-PCR-RFLP procedure (see Supporting Information,
Table S1).
Although increasing numbers of mycobacteria belonging to
the MTC are isolated from clinical samples, routine identiﬁ-
cation is not usually carried out to the species level. It is rel-
evant for public health control and treatment of infections
caused by members of the MTC that complete molecular
characterization is available by means of fast and accurate
assays capable of distinguishing among these mycobacteria.
Comparative genomics has demonstrated that sequences of
the mycobacterium bacillus may provide distinct molecular
signatures for the conclusive identiﬁcation of isolates at the
species level [6,11,12,23]. The gyrB gene encodes the B sub-
FIG. 1. Sequence analysis of gyrB genes. Comparative analysis of a segment of gyrB gene sequences from selected mycobacteria. The sequences
of the probe targets are typed in bold red and inside boxes and mismatches in relation to the consensus are typed in bold green. GenBank
accession numbers are indicated for each sequence.
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FIG. 2. Gold nanoprobe assay. (a) Colori-
metric assay (above) and respective spec-
trophotometry (below) for the
Mycobacterium tuberculosis complex (MTC)
probe (black lines represent the red solu-
tions associated with complementary tar-
get: non-aggregated Au-nanoprobes; the
grey line represents the blue solution asso-
ciated with noncomplementary target: agg-
regated Au-nanoprobe). The strains
analysed were: Mycobacterium tuberculosis
ATCC 25177 (1); Mycobacterium bovis LNI-
V 13027 (2) and LNIV 5530/0/05 (3); Myco-
bacterium caprae LNIV 17320 (4); and
Mycobacterium avium subsp. avium ATCC
25291 (5). (b) Nanoprobe aggregation as
measured by the ratio of aggregation (ratio
of SPR intensities at 526 and 600 nm) for
the assay mixtures. The bars represent the
average of three independent measure-
ments and the error bars indicate the sta-
ndard deviation. The dashed line
represents the threshold of one consid-
ered for discrimination between positive a-
nd negative detection with M. tuberculosis
complex probe DNA (10 mg/L) after 15 -
min of incubation with MgCl2 (0.04 M); de-
tection of M. tuberculosis probe DNA
(30 mg/L) after 15 min of incubation with
MgCl2 (0.07 M); detection of M. bovis pro-
be DNA (10 mg/L) after 15 min of incuba-
tion with MgCl2(0.07 M). The strains
analysed were: all strains of M. tuberculosis
(1); all strains of M. bovis (2); M. bovis BCG
(3); all strains of M. caprae (4); M. avium (-
5); M. avium subsp. paratuberculosis (6); M-
. avium subsp. hominissuis (7); and
Corynebacterium striatum (8).
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unit of DNA gyrase (topoisomerase II), an enzyme univer-
sally present in bacteria and essential for their replication. In
the present study, we developed a two-step approach based
on the PCR ampliﬁcation of the gyrB locus and subsequent
hybridization with a species-speciﬁc gold nanoprobe for the
unequivocal species identiﬁcation via a simple and fast
colorimetric assay capable of being introduced into routine
microbiology laboratory practice (see Supporting informa-
tion, Fig. S1) .
Speciﬁc DNA detection based on Au-nanoprobes has pro-
ven to be a fast and simple alternative to more cumbersome
techniques involving multistep assays. The non-cross-linking
method for DNA identiﬁcation has already been successfully
applied for the identiﬁcation of M. tuberculosis in clinical sam-
ples based on the rpoB locus [17].
The synthesized Au-nanoprobes were evaluated in terms
of their capability to identify the respective complementary
sequence. The minimum amount of salt (MgCl2) required to
cause full aggregation for each nanoprobe was determined
(data not shown), and these conditions were used for the
detection of targets. The solutions exhibit a strong red col-
our derived from the localized SPR of the gold nanoparticles.
In the presence of the respective complementary synthesized
target, the Au-nanoprobes were protected from aggregation
and the solution remained red, whereas the presence of
noncomplementary target did not protect the Au-nanop-
robes from aggregation and the solution turned blue
(Fig. 2a). Each probe was used in a minimum of three individ-
ual parallel hybridization experiments with the PCR-ampliﬁed
gyrB gene from each strain. Based on the UV-visible spectra
obtained after inducing aggregation, the ratio between the
absorbance at 526 nm (peak of the SPR, representing the
contribution of the non-aggregated fraction of Au-nanop-
robes) and absorbance at 600 nm (contribution from the
aggregated fraction of Au-nanoprobes) was calculated. A
ratio of one may be considered as the point of equilibrium
between non-aggregated and aggregated nanoprobe, and
hence the threshold by which to respectively consider the
positive and negative discrimination of sequences. The data
show that the MTC probe gave a clear positive identiﬁcation
for members of the MTC used in the assay, at the same time
as clearly recognizing M. avium complex species and C. stria-
tum as nonmembers (Fig. 2b; Table 1). The M. tuberculosis
probe unequivocally identiﬁed the respective target, as did
the M. bovis probe (Fig. 2b; Table 1). It should be noted that
the genomic sequences reveal the difference of only a single
nucleotide at the 3¢ end of the probe sequence but are still
perfectly capable of clear identiﬁcation of the respective tar-
gets. To evaluate the performance of the method, several
reference strains and clinical isolates including mycobacterial
and nonmycobacterial species were tested and successfully
identiﬁed (Table 1). The variation between individual experi-
ments showed very small inter-assay deviation (Fig. 2b). This
demonstrates the extreme sensitivity of the system and its
great potential for use in assays for identiﬁcation of very clo-
sely-related species. The Au-nanoprobe system that we pro-
pose is easy to perform without the need for expensive and
complex laboratory set up. After PCR ampliﬁcation, the Au-
nanoprobe system takes only 15 min to yield a colorimetric
result with high speciﬁcity and sensitivity [13,17–19,24], and,
using a microplate reader, is capable of considerable scaling-
up, making it suitable for high-throughput analysis. Indeed,
using the photometric function of the microplate reader,
each sample needs only 1 s to be assayed and the ratio cal-
culated (data not shown). The possibility of use via a porta-
ble assay platform is being tested to render this system
suitable for in-the-ﬁeld screening [16]. Future studies will be
carried out to optimize the methodology for application in
clinical samples, and to extend the range of application to
other members of the MTC.
The worldwide incidence of tuberculosis is still not
completely determined, in particular the incidence of
disease as a result of M. bovis and other non-M. tuberculosis
members of the MTC. A full understanding of the spectrum
of disease caused by MTC members requires the molecular
evaluation of mycobacterial isolates to the species level,
and assays such as the one described in the present study
may provide the additional screening potential required for
this task.
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Figure S1. (a) Schematic representation of DNA target
detection with gold nanoprobes. The red curve shows the
original Au nanoparticles spectra, indicating the strong red
colour.
Table S1. Blind identiﬁcation of clinical isolates using the
gold nanoprobe assay.
Please note: Wiley-Blackwell are not responsible for the
content or functionality of any supporting materials supplied
by the authors. Any queries (other than missing material)
should be directed to the corresponding author for the
article.
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